In order to achieve “a strong public health industrial base with resilient domestic supply chains for essential medicines, medical countermeasures and critical inputs,” US President Donald Trump has signed an executive order to enhance the security of the US pharmaceutical supply chain and reduce its dependence on foreign manufacturers.
President Trump has directed each executive department and agency to consider a variety of actions to increase their domestic procurement...







